<?xml version="1.0" encoding="UTF-8"?>
<ref id="ddr21709-bib-0195">
 <mixed-citation publication-type="journal" id="ddr21709-cit-0195">
  <string-name>
   <surname>Yao</surname>, 
   <given-names>X.</given-names>
  </string-name>, 
  <string-name>
   <surname>Ye</surname>, 
   <given-names>F.</given-names>
  </string-name>, 
  <string-name>
   <surname>Zhang</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Cui</surname>, 
   <given-names>C.</given-names>
  </string-name>, 
  <string-name>
   <surname>Huang</surname>, 
   <given-names>B.</given-names>
  </string-name>, 
  <string-name>
   <surname>Niu</surname>, 
   <given-names>P.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Liu</surname>, 
   <given-names>D.</given-names>
  </string-name> (
  <year>2020</year>). 
  <article-title>In vitro antiviral activity and projection of optimized dosing Design of Hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)</article-title>. 
  <source xml:lang="en">Clinical Infectious Diseases</source>. 
  <pub-id pub-id-type="doi">10.1093/cid/ciaa237</pub-id>
 </mixed-citation>
</ref>
